Article Versions Notes

Faltus C, Lahnsteiner A, Barrdahl M, Assenov Y, Hüsing A, Bogatyrova O, Laplana M, Johnson T, Muley T, Meister M, et al. Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International Journal of Molecular Sciences. 2022; 23(18):10699. https://doi.org/10.3390/ijms231810699

Faltus, Christian, Angelika Lahnsteiner, Myrto Barrdahl, Yassen Assenov, Anika Hüsing, Olga Bogatyrova, Marina Laplana, Theron Johnson, Thomas Muley, Michael Meister, and et al. 2022. "Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)" International Journal of Molecular Sciences 23, no. 18: 10699. https://doi.org/10.3390/ijms231810699

Faltus, C., Lahnsteiner, A., Barrdahl, M., Assenov, Y., Hüsing, A., Bogatyrova, O., Laplana, M., Johnson, T., Muley, T., Meister, M., Warth, A., Thomas, M., Plass, C., Kaaks, R., & Risch, A. (2022). Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International Journal of Molecular Sciences, 23(18), 10699. https://doi.org/10.3390/ijms231810699